Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease.
Rosangela PiccinniSusana G RodriguesMatteo MontaniGiuseppe MurgiaMaria G DelgadoStefania CasuGuido StirnimannNasser SemmoAndrea De GottardiJean-François DufourAnnalisa BerzigottiPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Steatosis is frequent in patients with cACLD and metabolic syndrome. CAP diagnostic accuracy for any steatosis and high-grade steatosis is good in this population. A CAP-IQR ≥40 dB/m does not impair CAP diagnostic accuracy in cACLD.